Triatomic Capital(@TriatomicCap):Pre-clinical science is super cool, but a lot of the potential speed & value from AI is downstream in the drug development process. @EdisonSci is applying their SotA agentic system there, too: "We are now deploying specialized Kosmos agents for Clinical Protocol Design and Regulatory Authoring to several of our partners, which can cut months off the amount of time needed to get molecules into the clinic, save companies tens of millions of dollars, and dramatically reduce the likelihood that submissions get stuck at the FDA."

Triatomic Capital

@TriatomicCap

‘AppliedAI’ in Deep tech, Health tech, & New economy // Helping great entrepreneurs build 'century-defining' technologies & businesses.

加入 January 2022

492 正在關注 700 粉絲

Triatomic Capital@TriatomicCap

2026.09.30 22:54

Pre-clinical science is super cool, but a lot of the potential speed & value from AI is downstream in the drug development process. @EdisonSci is applying their SotA agentic system there, too: "We are now deploying specialized Kosmos agents for Clinical Protocol Design and Regulatory Authoring to several of our partners, which can cut months off the amount of time needed to get molecules into the clinic, save companies tens of millions of dollars, and dramatically reduce the likelihood that submissions get stuck at the FDA."